APA (7th ed.) Citation

DP, K. (2015). Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome. Journal of neurology, 262(12), 2676. https://doi.org/10.1007/s00415-015-7897-y

Chicago Style (17th ed.) Citation

DP, Kidd. "Rituximab Is Effective in Severe Treatment-resistant Neurological Behçet's Syndrome." Journal of Neurology 262, no. 12 (2015): 2676. https://doi.org/10.1007/s00415-015-7897-y.

MLA (9th ed.) Citation

DP, Kidd. "Rituximab Is Effective in Severe Treatment-resistant Neurological Behçet's Syndrome." Journal of Neurology, vol. 262, no. 12, 2015, p. 2676, https://doi.org/10.1007/s00415-015-7897-y.